Pencarrow and Ahuahu Group have invested an undisclosed sum into the healthcare provider.
Hotly-contested auction came down to three bidders.
Report follows data revealed by NBR showing huge variation in certifier performance.
Performance fee doubles to $1.6m.
Majority shareholder expects $930m from sale of the Kiwi telco.
Chapman Tripp’s NZX50 funding report shows bank debt still king.
It did not ‘haul in’ everything but targeted sophisticated investors, Du Val says.
Performance fees also being charged against inappropriate benchmarks.
The Kiwi retailer biding its time about going toe-to-toe against Woolworths/Foodstuffs duopoly.
Central Otago prospect stirring investor interest despite early stage.